Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2

  • András Váradi
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
  • Gina F. Marrone
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
  • Travis C. Palmer
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
  • Ankita Narayan
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
  • Márton R. Szabó
    Institute of Biochemistry, Biological Research Centre, Hungarian Academy of Sciences, Szeged, H-6726 Hungary
  • Valerie Le Rouzic
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
  • Steven G. Grinnell
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
  • Joan J. Subrath
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
  • Evelyn Warner
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
  • Sanjay Kalra
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
  • Amanda Hunkele
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
  • Jeremy Pagirsky
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
  • Shainnel O. Eans
    Department of Pharmacodyanamics, University of Florida, Gainesville, Florida 032610, United States
  • Jessica M. Medina
    Department of Pharmacodyanamics, University of Florida, Gainesville, Florida 032610, United States
  • Jin Xu
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
  • Ying-Xian Pan
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
  • Attila Borics
    Institute of Biochemistry, Biological Research Centre, Hungarian Academy of Sciences, Szeged, H-6726 Hungary
  • Gavril W. Pasternak
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States
  • Jay P. McLaughlin
    Department of Pharmacodyanamics, University of Florida, Gainesville, Florida 032610, United States
  • Susruta Majumdar
    Molecular Pharmacology and Chemistry Program and Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States

Journal

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top